期刊文献+

IFN-λ1在HEK293T细胞中表达纯化及活性检测 被引量:1

Expression,purification and activity of IFN-λ1 in HEK293T cells
原文传递
导出
摘要 [目的]构建IFN-λ1真核表达质粒,利用人胚胎肾HEK293T细胞表达系统,获得具有良好生物学活性的IFN-λ1重组蛋白。[方法]将IFN-λ1目的基因克隆到pcDNA3.1+载体NheⅠ与XhoⅠ多克隆位点构建pcDNA3.1-IFN-λ1分泌表达质粒,并将其转染到HEK293T细胞中;采用Ni-NTA亲和层析方法分离纯化重组蛋白,SDS-PAGE和蛋白免疫印迹(Western Blotting)检测IFN-λ1的表达与纯度;采用qPCR、WB结合显微镜观察检测IFN-λ1的生物学活性。[结果]IFN-λ1真核表达质粒构建正确,而且能够在HEK293T细胞中分泌表达重组蛋白,分离纯化的IFN-λ1能够有效地诱导ISG15、ISG54、ISG56、OAS1、TNFα、MX1和TRAIL等凋亡相关基因的表达,激活p38促凋亡信号通路,抑制水泡性口炎病毒对BHK-21细胞的感染。[结论]成功构建了pcDNA3.1-IFN-λ1真核表达质粒,能够在HEK293T细胞中分泌表达IFN-λ1重组蛋白;分离纯化的IFN-λ1重组蛋白具有潜在的抗肿瘤和抗病毒生物学活性,为进一步研究IFN-λ1的功能和临床应用奠定了基础。 [Objective]To construct the eukaryotic expression plasmid of IFN-λ1,and to obtain the recombinant IFN-λ1 protein with good biological activity by using the human embryonic kidney HEK293 T cell expression system.[Method]The target IFN-λ1 gene was cloned into pcDNA3.1+vector NheⅠand XhoⅠpolyclonal sites to construct pcDNA3.1-IFN-λ1 expression plasmid.The recombinant protein was expression HEK293 T cells and isolated by Ni-NTA affinity chromatography.The expression level and purity of IFN-λ1 were assessed by SDS-PAGE and Western Blotting.Finally,The biological activity of IFN-λ1 was detected by qPCR,WB and microscope.[Result]The IFN-λ1 eukaryotic expression plasmid was correctly constructed,and the recombinant IFN-λ1 could be expressed in HEK293 T cells and secreted into cell culture supernatant The purified IFN-λ1 could effectively induce the expression of numerous apoptosis-related genes such as ISG15,ISG54,ISG56,OAS1,TNFα,MX1 and TRAIL,and activate the p38 pro-apoptotic signaling pathway.In addition,IFN-λ1 recombinant protein can also inhibit the infection of Vesicular Stomatitis Virus to BHK-21 cells.[Conclusion]The eukaryotic expression plasmid pcDNA3.1-IFN-λ1 was successfully constructed,which could secrete and express the recombinant protein IFN-λ1 in HEK293 T cells.The IFN-λ1 can be easily purified by Ni-NTA affinity chromatography from the cell culture supernatant.The purified recombinant IFN-λ1 protein has the potential of antitumor and antiviral biological activities,which lays a foundation for further study on IFN-λ1 function and clinical application.
作者 连丹花 任蕾颖 崔晓希 邵晓亚 李智涛 蒙雪琼 陈义祥 LIAN Dan-hua;REN Lei-ying;CUI Xiao-xi;SHAO Xiao-ya;LI Zhi-tao;MENG Xue-qiong;CHEN Yi-xiang(School of Basic Medical Science,Henan University of Science and Technology,Luoyang 471000,China)
出处 《生物技术》 CAS 2022年第6期677-683,共7页 Biotechnology
基金 河南省高等学校重点科研项目(22A310014) 河南省科技攻关重点项目(222102310300)。
关键词 IFN-λ1 HEK293T细胞 表达 纯化 生物学活性 IFN-λ1 HEK293T cell expression purification biological activity
  • 相关文献

参考文献3

二级参考文献11

  • 1刘畅,乔文涛,王琛,耿运琪.类泛素蛋白ISG 15及其在先天免疫中的作用[J].生物化学与生物物理进展,2006,33(11):1023-1029. 被引量:10
  • 2Kotenko SV, Gallagher G, Baurin VV, et al. IFNks mediate anti- viral protection through a distinct class H cytokine receptor com- plex [ J ]. Nat Immunol, 2003,4 ( 1 ) : 69 - 77.
  • 3Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class lI cytokine receptor IL-28R [ J]. Nat Immuno1,2003,4 ( 1 ) : 63 - 68.
  • 4Prokunina-Olsson L,Muchmore B, Tang W, et al. h variant up- stream of IFN-k3 (IL-28B) creating a new interferon gene IFN- k4 is associated with impaired clearance of hepatitis C virus [ J ]. Nat Genet,2013,45 (2) : 164 - 171.
  • 5Uze G, Monneron D. IL-28 and IL-29 :newcomers to the interferon family[ J]. Biochimie,2007,89 (6 - 7 ) :729 - 734.
  • 6Coccia EM, SeveraM, Giacomini E, et al. Viral infection and Toll- like receptor agonists induce a differential expression of type and k-interferon as inhuman plasmacytoid and monocyte-derived dendritic cells [ J ]. Eur J Immuno1,2004,34 (3) :796 - 805.
  • 7Gautier G,Humbert MD,eauviean F,et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12 p70 secretion by dendritic cells [ J ]. J Exp Med, 2005,201 (9) :1435 - 1446.
  • 8Witte K, Witte E, Sabat R, et al. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties [ J ]. Cytokine Growth Factor Rev,2010,21 (4) :237 -251.
  • 9Pagliaccetti NE, Robek MD. Interferon-h in the immune response to hepatitis B virus and hepatitis C virus [ J ]. J Interferon Cyto- kine Res,2010,30(8) :585 -590.
  • 10Muir A, Lawitz E, Ghalib R, et al. Pegylated interferon lambda (pegIFN,) phase 2 dose-ranging, active-controlled study in com- bination with ribavirin (RBV) for treatment-naive HCV patients ( genotypes 1,2,3, or 4) : safety, viral response, and impact of IL- 28B host genotype through week 12 [ J]. Hepatology, 2010,52 (Suppl 1) :715A.

共引文献3

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部